Effect of an OT antagonist on the control of the midcycle LH surge in women

Clin Endocrinol (Oxf). 2009 Jul;71(1):100-3. doi: 10.1111/j.1365-2265.2008.03456.x. Epub 2008 Oct 26.

Abstract

Objective: Data in women regarding the role of OT in LH secretion during the LH surge are conflicting. As in previous studies blood samples for LH measurements were taken infrequently, we re-examined this matter in women with a fully characterized midcycle LH surge.

Design: Normal women were studied over two cycles. When the dominant follicle reached a diameter of either 16-17 mm (Group 1) or 18-19 mm (Group 2), the women were infused intravenously for 3 h with normal saline (cycle-1) or atosiban (cycle-2).

Patients: Fifteen women (10 in group 1 and 5 in group 2) aged 23-35 years.

Measurements: Blood samples were obtained every 6 h to characterize the midcycle LH surge.

Results: The time interval (mean +/- SEM) from the start of the infusion to the onset of the LH surge in the two cycles was 46.8 +/- 4.8 and 45.6 +/- 9.6 h in group 1 and 6.0 +/- 2.4 and 7.5 +/- 2.8 h, respectively, in group 2. LH values during the LH surge were similar in the two cycles except in group 1 at the point of 30 h at which LH value in cycle-2 (41.2 +/- 4.6 mIU/ml) was significantly lower than in cycle-1 (52.8 +/- 3.4 mIU/ml, P < 0.05). Nevertheless, in each group, the area under the curve for LH was similar in the two cycles.

Conclusions: Antagonism of endogenous OT action by atosiban does not alter the LH profile during a fully characterized midcycle LH surge, suggesting that OT is not a major regulator of LH secretion in women.

MeSH terms

  • Adult
  • Female
  • Hormone Antagonists / administration & dosage*
  • Humans
  • Luteinizing Hormone / metabolism*
  • Ovarian Follicle / drug effects
  • Ovarian Follicle / metabolism*
  • Oxytocin / antagonists & inhibitors*
  • Vasotocin / administration & dosage
  • Vasotocin / analogs & derivatives*
  • Young Adult

Substances

  • Hormone Antagonists
  • atosiban
  • Oxytocin
  • Luteinizing Hormone
  • Vasotocin